https://ih.advfn.com/p.php?pid=nmona&article=76140321 Vielleicht ganz interessant:
Warrants As of September 30, 2017, and December 31, 2016, the Company had issued and outstanding warrants to the Company’s independent board member, to purchase up to two hundred and fifty thousand (250,000) shares of common stock at an exercise price of sixty-three cents ($0.63) per share. The warrants were fully-vested as of November 19, 2014, and expire on November 19, 2019. On August 31, 2017, the Company issued warrants to Anthony Baroud to purchase up to fifty thousand (50,000) shares of common stock at an exercise price of ninety-three cents ($0.93) per share. The warrants were fully vested as of August 31, 2017, and expire on March 1, 2018. The warrants were issued as consideration for a settlement agreement and mutual release of all claims between the Registrant and Anthony Baroud on August 31, 2017 (See Part II, Item 1).
Warrants As of September 30, 2017, and December 31, 2016, the Company had issued and outstanding warrants to the Company’s independent board member, to purchase up to two hundred and fifty thousand (250,000) shares of common stock at an exercise price of sixty-three cents ($0.63) per share. The warrants were fully-vested as of November 19, 2014, and expire on November 19, 2019. The grant date fair value of the warrants, as calculated based on the Black-Scholes valuation model, was $0.59 per share. As of September 30, 2017, as the exercise price per share is lower than the price per share of our common shares, the intrinsic value of outstanding warrants is $35,000. As of September 30, 2017, and December 31, 2016, the warrants issued to the Company’s independent board member had 1.5 and 2.2 years remaining until expiration.
Preferred Stock American Cannabis Company, Inc. is authorized to issue 5,000,000 shares of preferred stock at $0.01 par value. No shares of preferred stock were issued and outstanding during the three months or nine months ended September 30, 2017, and 2016 respectively. Common Stock American Cannabis Company, Inc. is authorized to issue 100,000,000 common shares at $0.00001 par value per share. The Company issued 0 shares of common stock for the three months ended September 30, 2017. For the nine months ended September 30, 2017, the Company issued 430,227 shares of common stock valued at $395,809 as follows: On January 4, 2017, the Company issued 200,000 common shares to Terry Buffalo. On January 4, 2017, the Company issued Sam D. Leucshen 50,000 common shares. On January 4, 2017, the Company issued Steven Lico 15,000 common shares. On January 4, 2017, the Company issued Tyler A. Schlosser 20,000 common shares. On January 4, 2017, the Company issued Robert Teran 50,000 common shares. On January 4, 2017, the Company issued Gayle Barr 4,727 common shares. On January 4, 2017, the Company issued Mica Renquist 7,500 common shares. On January 4, 2017, the Company issued Gary Altman 33,000 common shares. 10 On January 4, 2017, the Company issued Randy Fleming 50,000 common shares. On January 10, 2017, pursuant to the amended and restated Investment Agreement between the Company and Tangiers Global, LLC, the Company sold 588,841 registered common shares to Tangiers for $414,544 net of applicable financing costs received March 3, 2017. On February 22, 2017, pursuant to the amended and restated Investment Agreement between the Company and Tangiers Global, LLC, the Company sold 320,549 registered common shares to Tangiers for $188,143 net of applicable financing costs received on March 3, 2017. On June 12, 2017, the Company issued Jesus Quintero 8,955 shares of restricted common stock, valued at a price of $0.67 per share, value of $6,000. The shares were issued as consideration related to a severance agreement between the Company and Mr. Quintero. On December 28, 2016, the Company received conversion notice from a note holder to issue 237,885 shares of common stock for conversion of note principal of $25,000 and accrued interest of $2,000. The 237,885 shares of common stock were issued in January 2017.
|